Although mutation of NOTCH1 or NOTCH2 only occurs in a small proportion of breast cancer cases, inclusion of cases harboring both mutation and overexpression accounts for 30% of poor-prognosis TNBC cases. The gene discussed is NOTCH2; the disease is breast cancer.